These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32047261)

  • 1. Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity.
    Zhang LL; Guo J; Jiang XM; Chen XP; Wang YT; Li A; Lin LG; Li H; Lu JJ
    Acta Pharmacol Sin; 2020 May; 41(5):698-705. PubMed ID: 32047261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
    Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
    Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells.
    Zhang LL; Feng ZL; Su MX; Jiang XM; Chen X; Wang Y; Li A; Lin LG; Lu JJ
    Eur J Pharmacol; 2018 Jul; 830():17-25. PubMed ID: 29680228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells.
    Chen YC; Huang MY; Zhang LL; Feng ZL; Jiang XM; Yuan LW; Huang RY; Liu B; Yu H; Wang YT; Chen XP; Lin LG; Lu JJ
    Chin J Nat Med; 2020 Jul; 18(7):517-525. PubMed ID: 32616192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
    Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
    Jiang XY; Zhu XS; Xu HY; Zhao ZX; Li SY; Li SZ; Cai JH; Cao JM
    Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antiproliferative norditerpene dilactone, Nagilactone C, from Podocarpus neriifolius.
    Shrestha K; Banskota AH; Kodata S; Shrivastava SP; Strobel G; Gewali MB
    Phytomedicine; 2001 Nov; 8(6):489-91. PubMed ID: 11824527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.
    Xu L; Qiu S; Yang L; Xu H; Liu X; Fan S; Cui R; Fu W; Zhao C; Shen L; Wang L; Huang X
    Mol Carcinog; 2019 Aug; 58(8):1512-1525. PubMed ID: 31069881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an IKBKE inhibitor with antitumor activity in cancer cells overexpressing IKBKE.
    Liu T; Gao X; Xin Y
    Cytokine; 2019 Apr; 116():78-87. PubMed ID: 30685606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
    Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
    Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
    Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
    Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
    Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH
    Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
    Joshi KS; Rathos MJ; Mahajan P; Wagh V; Shenoy S; Bhatia D; Chile S; Sivakumar M; Maier A; Fiebig HH; Sharma S
    Mol Cancer Ther; 2007 Mar; 6(3):926-34. PubMed ID: 17363487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of P3971 an orally efficacious novel anticancer agent targeting HIF-1α and STAT3 pathways.
    Godse P; Kumar P; Yewalkar N; Deore V; Lohar M; Mundada R; Padgaonkar A; Manohar S; Joshi A; Bhatia D; Desai N; Damre A; Bhonde M; Joshi K; Sharma R; Kumar S
    Anticancer Agents Med Chem; 2013 Nov; 13(9):1460-6. PubMed ID: 24102269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.
    Dong C; Chen Y; Li H; Yang Y; Zhang H; Ke K; Shi XN; Liu X; Li L; Ma J; Kung HF; Chen C; Lin MC
    Int J Biol Sci; 2019; 15(7):1523-1532. PubMed ID: 31337981
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.
    Ni S; Chen X; Yu Q; Xu Y; Hu Z; Zhang J; Zhang W; Li B; Yang X; Mao F; Huang J; Sun Y; Li J; Jia L
    Eur J Med Chem; 2020 Jan; 185():111848. PubMed ID: 31732254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.